Vimarsana
Biggest News Aggregation in the World

Page 19 - Mark Wiggins News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Wiggins. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Wiggins Today - Breaking & Trending Today

TRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors - Vimarsana News

TRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Many large North Texas districts reporting more COVID-19 cases in January than last month - Vimarsana News

Many large North Texas districts reporting more COVID-19 cases in January than last month

Students, teachers and parents should remain vigilant against COVID-19, even as the holidays are done and students have returned to classrooms.

Source: wfaa.com
Swearing-in ceremony | Perry Newspapers - Vimarsana News

Swearing-in ceremony | Perry Newspapers

Swearing-in ceremony Shown (left to right) are: Sheriff Wayne Padgett, Property Appraiser Shawna Beach, Supervisor of Elections Dana Southerland, Blue, Tax Collector Mark Wiggins and Clerk of Court Gary Knowles. County Judge Bill Blue (center) presided over swearing-in ceremonies for Taylor County’s newly-elected and re-elected slate of constitutional officers Monday, Jan. 4. Subscribe to our e-Edition and read the rest of the story. Already a subscriber? Click here to sign in.

TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China ... - Vimarsana News

TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China ... TRACON Pharmaceuticals, Inc.December 30, 2020 GMT SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize i...

Source: apnews.com
TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab Oncology and 3D Medicines - Vimarsana News

TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab Oncology and 3D Medicines

TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab Oncology and 3D Medicines NDA was Submitted in November in the Indication of MSI-H/dMMR Cancer, Including Colorectal and Gastric Cancer December 30, 2020 08:05 ET | Source: TRACON Pharmaceuticals, Inc. TRACON Pharmaceuticals, Inc. San Diego, California, UNITED STATES SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical compa...